We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Efficient gene transfer into the mouse lung by fetal intratracheal injection of rAAV2/6.2.
- Authors
Carlon, Marianne; Toelen, Jaan; Van der Perren, Anke; Vandenberghe, Luk H; Reumers, Veerle; Sbragia, Lourenço; Gijsbers, Rik; Baekelandt, Veerle; Himmelreich, Uwe; Wilson, James M; Deprest, Jan; Debyser, Zeger
- Abstract
Fetal gene therapy is one of the possible new therapeutic strategies for congenital or perinatal diseases with high mortality or morbidity. We developed a novel delivery strategy to inject directly into the fetal mouse trachea. Intratracheal (i.t.) injection at embryonic day 18 (E18) was more efficient in targeting the fetal lung than conventional intra-amniotic (i.a.) delivery. Viral vectors derived from adeno-associated virus serotype 6.2, with tropism for the airway epithelium and not earlier tested in the fetal mouse lung, were injected into the fetal trachea. Bioluminescence (BL) imaging (BLI) was combined with magnetic resonance (MR) imaging (MRI) for noninvasive and accurate localization of transgene expression in vivo. Histological analysis for β-galactosidase (β-gal) revealed 17.5% of epithelial cells transduced in the conducting airways and 1.5% in the alveolar cells. Stable gene expression was observed up to 1 month after injection. This study demonstrates that direct injection of rAAV2/6.2 in the fetal mouse trachea is superior to i.a. delivery for transducing the lung. Second, as stable gene transfer was detected up to 1 postnatal month, this approach may be useful to evaluate fetal gene therapy for pulmonary diseases such as cystic fibrosis, requiring both substantial numbers of transduced cells as well as prolonged gene expression to obtain a stable phenotypic effect.
- Publication
Molecular therapy : the journal of the American Society of Gene Therapy, 2010, Vol 18, Issue 12, p2130
- ISSN
1525-0024
- Publication type
Journal Article
- DOI
10.1038/mt.2010.153